Insider · CIK 0002127744
Julian Michael Babarczy
Files at ATHE (ALTERITY THERAPEUTICS LTD). First filing -, latest -.
In brief
Julian Michael Babarczy files SEC Form 4 as director at ATHE (ALTERITY THERAPEUTICS LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Julian Michael Babarczy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | ATHE ALTERITY THERAPEUTICS LTD | AGrant or award Unlisted option exp 15 Jun 2031derivativeindirect: Vaucluse Investment Holdings Pty Ltd <Jigsaw Investment A/C> | +2,000,000 | $0.00 | $0 | 2,000,000 | Jun 23, 2026 |
Questions about Julian Michael Babarczy
Answered from the filings on this page, as of the latest one.
Is Julian Michael Babarczy buying or selling?
Julian Michael Babarczy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Julian Michael Babarczy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julian Michael Babarczy has 0.
Where does Julian Michael Babarczy file Form 4?
Julian Michael Babarczy has filed Form 4 at ATHE (ALTERITY THERAPEUTICS LTD). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.